K982328

Substantially Equivalent

BAYER ADVIA IMS SYSTEM (IN VITRO DIAGNOSTIC SYSTEM)

Applicant: Bayer Corp.
Product code: CJO
Advisory panel: Clinical Chemistry
Date received: 1998-07-02
Decision date: 1999-01-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.